Sep 14, 2026 08:33AM
Sep 14, 2026 08:30AM
Aug 25, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 3, 2026 08:03AM
Aug 3, 2026 08:00AM Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation
Jul 30, 2026 08:00AM
May 6, 2026 07:00AM
May 6, 2026 07:00AM
Mar 30, 2026 07:31AM
Mar 30, 2026 07:30AM
Feb 9, 2026 07:30AM
Jan 20, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)
Jan 6, 2026 07:30AM
Jan 6, 2026 07:30AM
Nov 14, 2025 07:31AM
Nov 14, 2025 07:30AM
Nov 14, 2025 07:30AM
Mar 31, 2025 06:43AM
Jul 29, 2024 07:15AM Anavex Life Sciences (AVXL): Results from Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference
Jul 28, 2024 05:00PM
Jul 28, 2024 05:00PM
Jul 22, 2024 07:01AM
May 22, 2024 07:37AM
May 22, 2024 07:30AM
May 9, 2024 07:30AM
Apr 29, 2024 07:15AM ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline
Apr 22, 2024 01:45AM
Apr 20, 2024 09:00PM
Apr 16, 2024 09:00PM
Apr 15, 2024 11:15AM
Apr 12, 2024 09:00PM
Apr 1, 2024 11:30AM
Mar 25, 2024 12:30PM ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against An
Mar 18, 2024 12:30PM
Mar 18, 2024 07:30AM
Mar 14, 2024 12:30PM
Feb 7, 2024 07:30AM
Jan 16, 2024 07:31AM
Jan 16, 2024 07:30AM
Jan 2, 2024 08:01AM Anavex Life Sciences (AVXL) Provides an Update on Rett Syndrome Program
Jan 2, 2024 08:00AM
Nov 6, 2023 08:00AM
Jun 28, 2023 07:30AM
Jun 28, 2023 07:30AM
Jun 12, 2023 07:30AM
Jun 6, 2023 07:30AM
May 9, 2023 07:30AM Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results
Mar 9, 2023 07:00AM

333,570 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All